PRICE T ROWE ASSOCIATES INC /MD/

Position in CTMX — CytomX Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$555,401

-$603,753 QoQ

Shares Held

148,107

-76.6% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#66

of 178 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. CTMX ranks #201 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$555,401	148,107	-76.6%	Shares	Defined	2026-08-14
2022-06-30	$1,159,154	633,418	-4.2%	Shares	Sole	2022-08-15
2022-03-31	$1,765,038	661,063	+0.2%	Shares	Sole	2022-05-16
2021-12-31	$2,857,206	659,863	-0.4%	Shares	Sole	2022-02-14
2021-09-30	$3,372,964	662,665	-3.7%	Shares	Sole	2021-11-15
2021-06-30	$4,357,090	688,324	-59.4%	Shares	Sole	2021-08-16
2021-03-31	$13,112,136	1,696,266	+147.1%	Shares	Sole	2021-05-17
2020-12-31	$4,496,404	686,474	-0.0%	Shares	Sole	2021-02-16
2020-09-30	$4,566,382	686,674	0.0%	Shares	Sole	2020-11-16
2020-06-30	$5,719,994	686,674	+0.0%	Shares	Sole	2020-08-14
2020-03-31	$5,264,672	686,398	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.